Biden says he wants to bring down drug prices. His actions tell a different story.

Los Angeles Times

24 March 2023 - You might get the impression from the Biden administration’s insulin price cut and its initiative allowing Medicare to negotiate over other pharmaceuticals that the drug pricing issue is finally being taken seriously in Washington.

Sadly, no.

Read Los Angeles Times article

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Medicine , US , Regulation , Pricing